Wright Medical Group NV (NASDAQ:WMGI) Director Elizabeth H. Weatherman Buys 15,000 Shares

Wright Medical Group NV (NASDAQ:WMGI) Director Elizabeth H. Weatherman bought 15,000 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were acquired at an average cost of $20.87 per share, with a total value of $313,050.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

WMGI stock traded up $0.19 on Thursday, hitting $21.01. The company had a trading volume of 1,453,068 shares, compared to its average volume of 1,640,367. Wright Medical Group NV has a 12-month low of $20.46 and a 12-month high of $32.86. The company has a current ratio of 0.91, a quick ratio of 0.70 and a debt-to-equity ratio of 0.79. The company has a 50-day moving average of $26.85. The company has a market capitalization of $2.63 billion, a PE ratio of 230.78, a price-to-earnings-growth ratio of 8.54 and a beta of 0.69.

Wright Medical Group (NASDAQ:WMGI) last issued its earnings results on Wednesday, August 7th. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.01. Wright Medical Group had a negative net margin of 14.65% and a positive return on equity of 1.37%. The company had revenue of $229.73 million for the quarter, compared to analysts’ expectations of $233.04 million. During the same quarter last year, the company posted ($0.03) earnings per share. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. Analysts anticipate that Wright Medical Group NV will post 0.17 earnings per share for the current year.



A number of equities analysts have weighed in on WMGI shares. Bank of America downgraded shares of Wright Medical Group from a “buy” rating to a “neutral” rating and set a $25.00 target price for the company. in a research note on Friday, August 9th. BidaskClub raised shares of Wright Medical Group from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Oppenheimer decreased their target price on shares of Wright Medical Group from $34.00 to $29.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Credit Suisse Group decreased their target price on shares of Wright Medical Group from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Finally, BMO Capital Markets reduced their price target on shares of Wright Medical Group from $36.00 to $30.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $31.38.

A number of hedge funds have recently modified their holdings of WMGI. Legal & General Group Plc increased its stake in shares of Wright Medical Group by 6.4% during the fourth quarter. Legal & General Group Plc now owns 49,172 shares of the medical device company’s stock valued at $1,339,000 after purchasing an additional 2,966 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Wright Medical Group by 54.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 885,249 shares of the medical device company’s stock valued at $24,095,000 after acquiring an additional 312,947 shares in the last quarter. Norges Bank bought a new stake in shares of Wright Medical Group during the fourth quarter valued at approximately $27,834,000. Geode Capital Management LLC increased its position in shares of Wright Medical Group by 7.9% during the fourth quarter. Geode Capital Management LLC now owns 1,323,373 shares of the medical device company’s stock valued at $36,022,000 after acquiring an additional 96,357 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV bought a new stake in shares of Wright Medical Group during the first quarter valued at approximately $267,000.

Wright Medical Group Company Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Featured Story: Put Option Volume

Insider Buying and Selling by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.